Tobias Tix

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Tobias Tix
Sep 22, 2024, 04:52 | Blog
Rahul Banerjee: Why CAR-T recipients may appear to be at increased SPM risk?
Rahul Banerjee shared a post by The Cancer Letter on X, adding: "Thanks The Cancer Letter for the…
Sep 14, 2024, 17:46 | Insight
Kai Rejeski: Second Primary Malignancies following CAR T-cell therapy
Kai Rejeski shared a post on X about a recent paper by Tobias Tix et…
Sep 11, 2024, 09:23 | Insight
Myeloma Paper of the Day, September 11th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Systematic review and meta-analysis of…
Jul 24, 2024, 08:12 | Insight
Meta-analysis of non-relapse mortality post-CAR-T cells in lymphoma and myeloma
Nature Medicine shared on X about a paper titled "A systematic review and meta-analysis of nonrelapse…
Jul 14, 2024, 01:25 | Insight
Piotr Wysocki: Nonrelapse mortality in CAR-T-treated patients. Beware of infections!
Piotr Wysocki recently posted on LinkedIn: "Cordas DM et al. conducted a systematic review and meta-analysis…
Jul 12, 2024, 19:08 | Insight
Interesting study - A meta-analysis of nonrelapse mortality after CAR T cell therapy
Vivek Subbiah shared on X: "Interesting study published in NatureMedicine: A systematic review and meta-analysis…
Jul 9, 2024, 06:46 | Blog
David Cordas dos Santos: Nonrelapse mortality after CAR-T cell treatment
David Cordas dos Santos, PostDoc at Dana-Farber Cancer Institute, made the following post on X:…
Jul 8, 2024, 17:31 | Insight
Kai Rejeski: Underestimated aspect of CAR T-cell therapy: non-relapse mortality
Kai Rejeski, Visiting investigator at Memorial Sloan Kettering Cancer Center, shared on X: “Hot off…
All: 8 Posts: 1 - 100
Special Coverage